Wittwer JE, Webster KE, Menz HB: A longitudinal study of measures of walking in people with Alzheimer's Disease. Gait Posture. 2010, 32: 113-117. 10.1016/j.gaitpost.2010.04.001.
Article
PubMed
Google Scholar
Pettersson AF, Olsson E, Wahlund LO: Motor function in subjects with mild cognitive impairment and early Alzheimer's disease. Dement Geriatr Cogn Disord. 2005, 19: 299-304. 10.1159/000084555.
Article
CAS
PubMed
Google Scholar
Eggermont LH, Gavett B, Volkers KM, Blankevoort CG, Scherder EJ, Jefferson AL, Steinberg E, Nair A, Green RC, Stern RA: Lower-extremity function in cognitively healthy aging, mild cognitive impairment, and Alzheimer's disease. Arch Phys Med Rehabil. 2010, 91: 584-588. 10.1016/j.apmr.2009.11.020.
Article
PubMed Central
PubMed
Google Scholar
Nadkarni NK, Mawji E, McIlroy WE, Black SE: Spatial and temporal gait parameters in Alzheimer's disease and aging. Gait Posture. 2009, 30: 452-454. 10.1016/j.gaitpost.2009.07.003.
Article
PubMed Central
PubMed
Google Scholar
Alexander NB: Gait disorders in older adults. J Am Geriatr Soc. 1996, 44: 434-451.
Article
CAS
PubMed
Google Scholar
Andersen CK, Wittrup-Jensen KU, Lolk A, Andersen K, Kragh-Sorensen P: Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes. 2004, 2: 52-10.1186/1477-7525-2-52.
Article
PubMed Central
PubMed
Google Scholar
Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M: Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer’s Disease Cooperative Study. Neurology. 1999, 52: 714-718. 10.1212/WNL.52.4.714.
Article
CAS
PubMed
Google Scholar
van Dijk PT, Mehr DR, Ooms ME, Madsen R, Petroski G, Frijters DH, Pot AM, Ribbe MW: Comorbidity and 1-year mortality risks in nursing home residents. J Am Geriatr Soc. 2005, 53: 660-665. 10.1111/j.1532-5415.2005.53216.x.
Article
PubMed
Google Scholar
Prigerson HG: Costs to society of family caregiving for patients with end-stage Alzheimer's disease. N Engl J Med. 2003, 349: 1891-1892. 10.1056/NEJMp038157.
Article
PubMed
Google Scholar
Allan LM, Ballard CG, Burn DJ, Kenny RA: Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. J Am Geriatr Soc. 2005, 53: 1681-1687. 10.1111/j.1532-5415.2005.53552.x.
Article
PubMed
Google Scholar
Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG: Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006, 77: 585-589. 10.1136/jnnp.2005.081711.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mossey JM, Gallagher RM, Tirumalasetti F: The effects of pain and depression on physical functioning in elderly residents of a continuing care retirement community. Pain Med. 2000, 1: 340-350. 10.1046/j.1526-4637.2000.00040.x.
Article
CAS
PubMed
Google Scholar
Gillette-Guyonnet S, Nourhashemi F, Andrieu S, Cantet C, Micas M, Ousset PJ, Vellas B: The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging. 2003, 7: 91-96.
CAS
PubMed
Google Scholar
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984, 34: 939-944. 10.1212/WNL.34.7.939.
Article
CAS
PubMed
Google Scholar
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963, 185: 914-919. 10.1001/jama.1963.03060120024016.
Article
CAS
PubMed
Google Scholar
Zarit SH, Reever KE, Bach-Peterson J: Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980, 20: 649-655. 10.1093/geront/20.6.649.
Article
CAS
PubMed
Google Scholar
Folstein MF, Folstein SE, McHugh PR: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-198. 10.1016/0022-3956(75)90026-6.
Article
CAS
PubMed
Google Scholar
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994, 44: 2308-2314. 10.1212/WNL.44.12.2308.
Article
CAS
PubMed
Google Scholar
Guigoz Y, Lauque S, Vellas BJ: Identifying the elderly at risk for malnutrition, The Mini Nutritional Assessment. Clin Geriatr Med. 2002, 18: 737-757. 10.1016/S0749-0690(02)00059-9.
Article
PubMed
Google Scholar
Vellas BJ, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ, Garry PJ: One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc. 1997, 45: 735-738.
Article
CAS
PubMed
Google Scholar
Desquilbet L, Meyer L: Time-dependent covariates in the Cox proportional hazards model. Theory and practice. Rev Epidemiol Sante Publique. 2005, 53: 51-68. 10.1016/S0398-7620(05)84572-9.
Article
CAS
PubMed
Google Scholar
Potkin SG: The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients. Int Psychogeriatr. 2002, 14: 7-26.
Article
PubMed
Google Scholar
Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y: Motor signs during the course of Alzheimer disease. Neurology. 2004, 63: 975-982. 10.1212/01.WNL.0000138440.39918.0C.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hebert LE, Scherr PA, McCann JJ, Bienias JL, Evans DA: Change in direct measures of physical performance among persons with Alzheimer's disease. Aging Ment Health. 2008, 12: 729-734. 10.1080/13607860802154390.
Article
PubMed
Google Scholar
Karvonen-Gutierrez CA, Ylitalo KR: Prevalence and correlates of disability in a late middle-aged population of women. J Aging Health. 2013, 25: 701-717. 10.1177/0898264313488165.
Article
PubMed Central
PubMed
Google Scholar
Gill TM, Murphy TE, Gahbauer EA, Allore HG: Association of injurious falls with disability outcomes and nursing home admissions in community-living older persons. Am J Epidemiol. 2013, 178: 418-425. 10.1093/aje/kws554.
Article
PubMed Central
PubMed
Google Scholar
Rolland Y, Pillard F, Lauwers-Cances V, Busquere F, Vellas B, Lafont C: Rehabilitation outcome of elderly patients with hip fracture and cognitive impairment. Disabil Rehabil. 2004, 26: 425-431. 10.1080/09638280410001663148.
Article
PubMed
Google Scholar
Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Moller HJ, Rogers SL, Friedhoff LT: The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord. 1999, 10: 237-244. 10.1159/000017126.
Article
CAS
PubMed
Google Scholar
Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 2001, 57: 613-620. 10.1212/WNL.57.4.613.
Article
CAS
PubMed
Google Scholar
Wilcock GK, Lilienfeld S, Gaens E: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group. BMJ. 2000, 321: 1445-1449. 10.1136/bmj.321.7274.1445.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E: A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc. 2001, 49: 1590-1599. 10.1111/j.1532-5415.2001.49266.x.
Article
CAS
PubMed
Google Scholar
Hansen RA, Gartlehner G, Lohr KN, Kaufer DI: Functional outcomes of drug treatment in Alzheimer's disease: a systematic review and meta-analysis. Drugs Aging. 2007, 24: 155-167. 10.2165/00002512-200724020-00007.
Article
CAS
PubMed
Google Scholar
Munoz-Torrero D: Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease. Curr Med Chem. 2008, 15: 2433-2455. 10.2174/092986708785909067.
Article
CAS
PubMed
Google Scholar
Birks J: Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006, 4: CD005593
Google Scholar
Vellas B, Cunha L, Gertz HJ, De Deyn PP, Wesnes K, Hammond G, Schwalen S: Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease. Curr Med Res Opin. 2005, 21: 1423-1429. 10.1185/030079905X61884.
Article
CAS
PubMed
Google Scholar
Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O: Galantamine improves gait performance in patients with Alzheimer's disease. J Am Geriatr Soc. 2008, 56: 946-947. 10.1111/j.1532-5415.2008.01657.x.
Article
PubMed
Google Scholar
Grossberg GT: The ABC of Alzheimer's disease: behavioral symptoms and their treatment. Int Psychogeriatr. 2002, 14: 27-49. 10.1017/S1041610203008652.
Article
PubMed
Google Scholar
Roher AE, Esh CL, Kokjohn TA, Castano EM, Van Vickle GD, Kalback WM, Patton RL, Luehrs DC, Daugs ID, Kuo YM, Emmerling MR, Soares H, Quinn JF, Kaye J, Connor DJ, Silverberg NB, Adler CH, Seward JD, Beach TG, Sabbagh MN: Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement. 2009, 5: 18-29. 10.1016/j.jalz.2008.10.004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ogura H, Kosasa T, Kuriya Y, Yamanishi Y: Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats. Eur J Pharmacol. 2001, 415: 157-164. 10.1016/S0014-2999(01)00824-X.
Article
CAS
PubMed
Google Scholar
Lyell V, Ranatunga KW, Allain T: Cholinesterase inhibitors and peripheral neuromuscular function in dementia. J Am Geriatr Soc. 2009, 57: 2354-2356. 10.1111/j.1532-5415.2009.02598.x.
Article
PubMed
Google Scholar
Koyama A, O'Brien J, Weuve J, Blacker D, Metti AL, Yaffe K: The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2013, 68: 433-440. 10.1093/gerona/gls187.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pavlov VA, Tracey KJ: Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans. 2006, 34: 1037-1040. 10.1042/BST0341037.
Article
CAS
PubMed
Google Scholar
Arikawa M, Kakinuma Y, Handa T, Yamasaki F, Sato T: Donepezil, anti-Alzheimer's disease drug, prevents cardiac rupture during acute phase of myocardial infarction in mice. PLoS One. 2011, 6: e20629-10.1371/journal.pone.0020629.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gardette V, Andrieu S, Lapeyre-Mestre M, Coley N, Cantet C, Ousset PJ, Grand A, Monstastruc JL, Vellas B: Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study. CNS Drugs. 2010, 24: 431-442. 10.2165/11318010-000000000-00000.
Article
CAS
PubMed
Google Scholar